Neurosteroids enhance the viability of staurosporine and doxorubicin treated differentiated human neuroblastoma SH-SY5Y cells

Pharmacological Reports

Volumn 60, Issue 5, 2008, Pages 686-691

  Leśkiewicz, Monika ^a   Regulska, Magdalena ^a   Budziszewska, Bogusława ^a   Jantas, Danuta ^a   Jaworska Feil, Lucylla ^a   Basta Kaim, Agnieszka ^a   Kubera, Marta ^a   Lasoń, Władysław ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Calcein; Dehydroepiandrosterone; Differentiated SH SY5Y cells; Doxorubicin; Lactate dehydrogenase; Phosphatidylinositol 3 kinase; Pregnenolone; Staurosporine

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CALCEIN; DOXORUBICIN; LACTATE DEHYDROGENASE; NEUROSTEROID; PHOSPHATIDYLINOSITOL 3 KINASE; PRASTERONE; PRASTERONE SULFATE; PREGNENOLONE; STAUROSPORINE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ANTINEOPLASTIC ANTIBIOTIC; CARCINOGEN; CHROMONE DERIVATIVE; DIAGNOSTIC AGENT; ENZYME INHIBITOR; FLUORESCEIN DERIVATIVE; MORPHOLINE DERIVATIVE; RETINOIC ACID; STEROID; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL DIFFERENTIATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; HUMAN; HUMAN CELL; MITOCHONDRION; NEUROBLASTOMA CELL; NEUROPROTECTION; BRAIN TUMOR; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NEUROBLASTOMA; PATHOLOGY; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BRAIN NEOPLASMS; CARCINOGENS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; CHROMONES; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DOXORUBICIN; ENZYME INHIBITORS; FLUORESCEINS; HUMANS; L-LACTATE DEHYDROGENASE; MORPHOLINES; NEUROBLASTOMA; PREGNENOLONE; STAUROSPORINE; STEROIDS; TRETINOIN;

EID: 57849114809     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bastianetto S, Ramassamy C, Poirier J, Quirion R: Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res, 1999, 66, 35-41.
2. Bian X, McAllister-Lucas LM, Shao F, Schumacher KR, Feng Z, Porter AG, Castle VP, Opipari AW Jr: NF-κB activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J Biol Chem, 2001, 276, 48921-48929.
3. Bucolo C, Drago F, Lin LR, Reddy VN: Neuroactive steroids protect retinal pigment epithelium against oxidative stress. Neuroreport, 2005, 16, 1203-1207.
4. Gursoy E, Cardounel A, Kalimi M: Pregnenolone protects mouse hippocampal (HT-22) cells against glutamate and amyloid beta protein toxicity. Neurochem Res, 2001, 26, 15-21.
5. Guth L, Zhang Z, Roberts E: Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury. Proc Natl Acad Sci U S A, 1994, 91, 12308-12312.
6. Friesen C, Fulda S, Debatin KM: Deficient activation of the CD95 (APO-1/ Fas) system in drug-resistant cells. Leukemia, 1997, 11, 1833-1841.
7. 2+ in cultured rat hippocampal neurons. Neurosci Lett, 1992, 141, 30-34.
8. Kaasik A, Kalda A, Jaako K, Zharkovsky A:. Dehydroepiandrosterone sulphate prevents oxygen-glucose deprivation-induced injury in cerebellar granule cell culture. Neuroscience, 2001, 102, 427-432.
9. Kimonides VG, Khatibi NH, Svendsen CN, Sofroniew MV, Herbert J: Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci U S A, 1998, 95, 1852-1857.
10. Kimonides VG, Spillantini MG, Sofroniew MV, Fawcett JW, Herbert J: Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures. Neuroscience, 1999, 89, 429-436.
11. Leśkiewicz M, Regulska M, Budziszewska B, Jantas D, Jaworska-Feil L, Basta-Kaim A, Kubera M et al.: Effects of neurosteroids on hydrogen peroxide- and staurosporine-induced damage of human neuroblastoma SH-SY5Y cells. J Neurosci Res, 2008, 86, 1361-1370.
12. Mao X, Barger SW: Neuroprotection by dehydroepiandrosterone-sulfate: role of an NF-κB-like factor. Neuroreport, 1998, 9, 759-763.
13. A receptors. Acta Neurobiol Exp (Wars), 2007, 67, 219-233.
14. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM: Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science, 1986, 232, 1004-1007.
15. Maurice T, Phan VL, Urani A, Kamei H, Noda Y, Nabeshima T: Neuroactive neurosteroids as endogenous effectors for the sigma1 (σ1) receptor: pharmacological evidence and therapeutic opportunities. Jpn J Pharmacol, 1999, 81, 125-155.
16. Maurice T, Grégoire C, Espallergues J: Neuro(active)-steroids actions at the neuromodulatory sigma1 (σ1) receptor: biochemical and physiological evidences, consequences in neuroprotection. Pharmacol Biochem Behav, 2006, 84, 581-597.
17. Mellon SH, Griffin LD, Compagnone NA: Biosynthesis and action of neurosteroids. Brain Res Brain Res Rev, 2001, 37, 3-12.
18. Poulaki V, Mitsiades CS, Mitsiades N: The role of Fas and FasL as mediators of anticancer chemotherapy. Drug Resist Updat, 2001, 4, 233-242.
19. Prince JA, Oreland L: Staurosporine differentiated human SH-SY5Y neuroblastoma cultures exhibit transient apoptosis and trophic factor independence. Brain Res Bull, 1997, 43, 515-523.
20. Reddy DS, Kulkarni SK: Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydroepiandrosterone sulphate in mice. Eur J Pharmacol, 1998, 345, 55-59.
21. Regulska M, Leśkiewicz M, Budziszewska B, Kutner A, Jantas D, Basta-Kaim A, Kubera M et al.: Inhibitory effects of 1,25-dihydroxyvitamin D(3) and its low-calcemic analogues on staurosporine-induced apoptosis. Pharmacol Rep, 2007, 59, 393-401.
22. Saeki M, Maeda S, Wada K, Kamisaki Y: Insulin-like growth factor-1 protects peroxynitrite-induced cell death by preventing cytochrome c-induced caspase-3 activation. J Cell Biochem, 2002, 84, 708-716.
23. Shirakawa H, Katsuki H, Kume T, Kaneko S, Ito J, Akaike A: Regulation of N-methyl-D-aspartate cytotoxicity by neuroactive steroids in rat cortical neurons. Eur J Pharmacol, 2002, 454, 165-175.
24. Takahashi H, Nakajima A, Sekihara H: Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) inhibit the apoptosis in human peripheral blood lymphocytes. J Steroid Biochem Mol Biol, 2004, 88, 261-264.
25. Weaver CE, Wu FS, Gibbs TT, Farb DH: Pregnenolone sulfate exacerbates NMDA-induced death of hippocampal neurons. Brain Res, 1998, 803, 129-136.
26. Yang NC, Jeng KC, Ho WM, Chou SJ, Hu ML: DHEA inhibits cell growth and induces apoptosis in BV-2 cells and the effects are inversely associated with glucose concentration in the medium. J Steroid Biochem Mol Biol, 2000, 75, 159-166.
27. Zhang L, Li B, Ma W, Barker JL, Chang YH, Zhao W, Rubinow DR: Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways. Brain Res Mol Brain Res, 2002, 98, 58-66.